Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Ensysce Biosciences Inc
ENSC
Alternate Symbol(s):
ENSCW
Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company. The Company develops solutions for severe pain relief while reducing the potential for opioid misuse, abuse, and overdose. Its pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection (TAAP) platform, and an over-dose protection opioid prodrug technology...
, the Multi-Pill Abuse Resistant (MPAR) platform. Its lead product, PF614, is a TAAP extended-release oxycodone and a potential analgesic to treat severe pain. Its second product, PF614-MPAR, is to treat severe pain with the added benefit of oral overdose protection, is a combination product of the TAAP prodrug PF614 with a trypsin inhibitor. Additionally, nafamostat, which is an ingredient in its overdose protection combination products, is also being developed for the intended purpose of treating infection and pulmonary lung diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ENSC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(214)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Apr 23, 2025 8:54am
Buy buddy buy because it's taking off this morning.
This stock is signalling a big upswing for it today and
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 07, 2024 10:22am
ENSC....almost 100 million shares have traded
Yes there was a trade to be made....my bad ! Now tell me....what will be tomorrows news.....any guesses????? Come on Audience......let me hear what your thoughts are!!!!!
Largest Integrated Facility Services Provider in Canada Releases Financial Results for Q1, 2025
posted May 11, 2025 9:00am by
GDI Integrated Facility Services Inc.
-
|
Adjusted EBITDA* amounted to $34 million, representing an Adjusted EBITDA* margin of 6% compared to $28 million and 4% in Q1 2024. Net income was $6 million or $0.26 per share compared to $0.4 million or $0.02 per share in Q1 2024.Long-term debt, net of cash* decreased by $14 million in the quarter ...read more
(103)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 07, 2024 9:00am
ENSC....don't even think about Chasing !!!!!
Currently trading at $0.715 on over 10 million shares...here is this a.m's NR : Ensysce Biosciences Receives Positive Nasdaq Listing Determination 2024-11-07 05:13 ET - News
...more
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 02, 2024 9:44am
Ensysce Biosciences, Inc. (NASDAQ:ENSC): Developing Safer Pr
https://beyondspx.com/2024/08/01/ensysce-biosciences-inc-nasdaqensc-developing-safer-prescription-drugs-through-innovative-abuse-and-overdose-resistant-technologies/
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 07, 2023 9:56am
New Press Release - Ensysce Biosciences Releases Updated Investor Presentation Available Via Investor Relations Website
SAN DIEGO, CA / ACCESSWIRE / June 7, 2023 / Ensysce Biosciences, Inc. (NASDAQ:ENSC), a clinical-stage company applying transformative chemistry to improve prescription drug safety, today announced an updated investor presentation has been posted to the Company's investor relations website. The...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Jun 06, 2023 8:05am
New Press Release - Ensysce Biosciences to Participate in Upcoming Industry Events
Chief Medical Officer, Dr. William Schmidt, to Present at the CPDD 85th Annual Scientific MeetingChief Commercial Officer, Geoff Birkett, to Present Opening Address at EPHMRA 2023 Annual ConferenceSAN DIEGO, CA / ACCESSWIRE / June 6, 2023 / Ensysce Biosciences, Inc. (NASDAQ:ENSC), a clinical...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on May 15, 2023 4:30pm
New Press Release - Ensysce Biosciences Reports First Quarter 2023 Financial Results
Recently Completed Successful Ground-Breaking Study on Overdose Protection Recently Completed $7 Million Public OfferingSAN DIEGO, CA / ACCESSWIRE / May 15, 2023 /Ensysce Biosciences, Inc. ("Ensysce" or the "Company")(NASDAQ:ENSC), a clinical-stage company applying transformative chemistry to...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on May 12, 2023 4:40pm
New Press Release - Ensysce Biosciences, Inc. Announces Closing of $7 Million Public Offering
SAN DIEGO, CA / ACCESSWIRE / May 12, 2023 / Ensysce Biosciences, Inc.(NASDAQ:ENSC) (the "Company"), a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety to reduce abuse and overdose, announced today the closing of the previously announced public...
read article.
(103)
•••
Iseneschal
X
Post by
Iseneschal
on May 10, 2023 8:58am
ENSC.... I have to give kudos to ENSC
I found this Co played by the rules and they were transparent enough to be able to pick spots to enter and exit. Most Co's are the complete opposite Cheers and Good Luck to ENSC !
(0)
•••
PressRelease
X
Post by
PressRelease
on May 10, 2023 8:03am
New Press Release - Ensysce Biosciences, Inc. Announces Pricing of $7 Million Public Offering
SAN DIEGO, CA / ACCESSWIRE / May 10, 2023 / Ensysce Biosciences, Inc.(NASDAQ:ENSC) (the "Company"), a clinical-stage biotech company applying transformative chemistry to improve prescription drug safety to reduce abuse and overdose, announced today announced the pricing of a public offering of an...
read article.
(103)
•••
Iseneschal
X
Post by
Iseneschal
on May 09, 2023 12:57pm
ENSC....filed yesterday...Check it out!
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716947/000149315223015752
(103)
•••
Iseneschal
X
Post by
Iseneschal
on May 09, 2023 9:38am
ENSC..... Great way to start off the morning ; )
That's a big F'king Cha Ching Sold all into the strength...... I feel confident this will go even higher ...past $7..... Remember...they will want to raise money I bet this will be a double
...more
(103)
•••
Iseneschal
X
Post by
Iseneschal
on May 09, 2023 9:10am
ENSC.... Seems to me that this should go much higher
Based on past performance..... ENSC traded almost 4.5 million shares on 04/19/23 just on this NR: Ensysce CEO Dr. Lynn Kirkpatrick To Present Featured Case Study of MPAR Overdose Protection Platform
...more
(103)
•••
Iseneschal
X
Post by
Iseneschal
on May 09, 2023 8:45am
ENSC..Great morning Folks...NR and volume/ sh price increase
Cheers !! Ensysce Biosciences Announces Successful Completion of Ground-Breaking Study on Overdose Protection 2023-05-09 05:02 PT - News Release ~ Represents Major Milestone Towards Launch of
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on May 09, 2023 8:01am
New Press Release - Ensysce Biosciences Announces Successful Completion of Ground-Breaking Study on Overdose Protection
~ Represents Major Milestone Towards Launch of PF614-MPAR ~~ PF614-MPAR on Track to be the First Drug to Protect Against Overdose ~SAN DIEGO, CA / ACCESSWIRE / May 9, 2023 / Ensysce Biosciences, Inc. (NASDAQ:ENSC), clinical-stage biotech company applying transformative chemistry to improve...
read article.
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >